(Bloomberg) -- Bristol Myers Squibb Co. said its new schizophrenia drug is off to a better start than similar recently ... The medication, to be sold under the name Cobenfy, was a key piece ...

Bristol Myers Squibb CEO Chris Boerner described his company's new drug, Cobenfy, which can be used to treat psychiatric disorders like schizophrenia. He said the treatment is effective but doesn ...

Bristol Myers (BMY) new psychiatric drug Cobenfy is effective in treating schizophrenia without “the serious side effects’ of other older therapies, writes Julie Coleman for CNBC..Bristol ...

Bristol Myers Squibb CEO Chris Boerner described his company's new drug, Cobenfy, which can be used ... Get local news you need to know to start your day with NBC 6's News Headlines newsletter.